Pharma Focus Europe

Advisory Board

The Pharma Focus Europe Advisory Board guides our current and upcoming leaders in the pharmaceutical sector in working smarter and faster. We offer provocative insights, practical tactics, and informative articles to enhance execution.

Kishore Hotha

Kishore Hotha

Global Global Vice President R&D Lab Operations, Veranova, USA

Dr. Kishore Hotha is a scientific & business leader in the pharmaceutical biotech & CDMO. He contributed several IND, NDA & ANDAs of drug substances and products in small and large molecules, ADCs, Oligos, and peptides. He holds a Ph.D. from JNT University and an MBA from SNHU. Currently serving as Global VP at Veranova, his career includes pivotal roles at Lupin and Dr. Reddy’s, and he has contributed to over 50 publications and serving editorial boards.

Joab Williamson

Joab Williamson

Director, Clinical Operations, Faron Pharmaceuticals Ltd., United Kingdom

Joab Williamson is the Director, Clinical Operations at Faron Pharmaceuticals, a clinical stage biotech focusing on building the future of immune-oncology. In this role, Joab is responsible for the full oversight of clinical trials, and leading clinical strategy. He is also a PhD researcher with work focusing on how regulatory processes influence investment decisions and development timelines through the pharmaceutical industry.

Scott M. Wheelwright

Scott M. Wheelwright

Chief Operating Officer, BioInno Bioscience Co., Ltd. China
Scott M. Wheelwright, Ph.D., is the founding Chief Operating Officer of BioInno Bioscience, a contract development and manufacturing organization (CDMO) in China that provides GMP production of antibodies, cell therapies, and gene therapies. Dr. Wheelwright was the founding COO of Innovent Biologics in China in 2010, a major biotech company in China. Dr. Wheelwright was a founder and principal of the consulting firms Strategic Manufacturing Worldwide, Inc. (located in Arizona), and Complya Asia (located in China).  Dr. Wheelwright has thirty years of experience in bringing novel products to market, including new drug applications (BLAs and NDAs) in the US and Japan.

 

Gustavo Samojeden

Gustavo Samojeden

CEO, Eriochem S.A, Argentina

Gustavo Samojeden is a Managing Director & CEO of Eriochem S.A. He is responsible for the full P&L of the group companies in Argentina, USA, Uruguay, Brazil, and México, and direct report to the group President. He is also a board member of the Uruguay affiliate. 

Juris Hmelnickis

Juris Hmelnickis

CEO, Grindeks, Latvia

In 2020 Juris became the Chairman of the Board of JSC Grindeks. Along with active professional activity in JSC Grindeks, he also held leading positions in the company’s subsidiary Kalceks. Currently, Hmelnickis holds the position of a member of the Board of Kalceks.

Dmitrii Vitalievich Kriuchkov

Dmitrii Vitalievich Kriuchkov

Executive Director, Axon Clinical Trial Lab, Russia

MD., MSc (Drug Development), GxP Auditor and Consultant with over 15 years experience in Clinical Research in various therapeutic areas (Oncology, Cardiovascular, Rheumatology, Infectious Diseases, Endocrinology, Dermatology, Pulmonology, Hematology, Rare diseases) and all phases of clinical trials (I to IV), Bioequivalence, Non-International Studies.

Nigel Cryer FRSC

Nigel Cryer FRSC

Global Corporate Quality Audit Head, Sanofi Pasteur, France

Nigel has been a senior executive in pharmaceutical, biotech, and logistics, mainly working in global companies, and has over 25 years of experience in technical, managerial, and quality aspects of the life science industry, from APIs, cell cultures, to finished sterile products. He has worked with global companies such as AstraZeneca, MSD (Merck & Co), DHL Lifesciences, Roche, Johnson & Johnson, and Sanofi.

Hoda Gamal

Hoda Gamal

Director of Regulatory and Corporate Affairs Middle East and Africa, Allied associate, Egypt

Regulatory Affairs and Governmental Lead with great experience at multinational pharmaceutical companies in general management, regulatory affairs, quality assurance, business development, and strategic planning across key markets.

Hassan Mostafa Mohamed

Hassan Mostafa Mohamed

Chairman & Chief Executive Officer, ReyadaPro, Saudi Arabia

Dr. Hassan Mostafa Mohamed, Chairman & Chief Executive Officer at ReyadaPro is an entrepreneurial and growth-driven executive with more than 25 years of experience in pharmaceutical industries, including, Technical, sales & marketing, Production, Supply chain, Engineering/utilities, Quality, and regulatory issues. Mr Hassan is an expert in driving pharmaceutical facilities to accomplish corporate goals, building and leading technical & quality aspects with market consideration for rapid growth, and efficient operational excellence.

Teresa Derbiszewska

Teresa Derbiszewska

Clinical Quality Director, G42 Healthcare/IROS, UAE

Teresa Derbiszewska has over 20 years of experience in the pharmaceutical industry including the last 17 years in the field of medical clinical trials, working for the leading, global Clinical Research Organizations (CRO): Parexel, ICON, and PPD. She is currently the Clinical Quality Assurance Director for Insights Research Organization & Solutions (IROS) the first United Arab Emirates (UAE) - based Contract Research Organization (CRO) specializing in healthcare clinical trial research.

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva